The Role of DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer
Автор: Research To Practice
Загружено: 2025-05-07
Просмотров: 535
Описание:
Understanding the Current Paradigm and New Approaches: The Role of DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer (Symposium Video Proceedings)
Proceedings from a live event on April 11, 2025, held during the 2025 Annual ONS Congress and moderated by Dr Neil Love. Featuring perspectives from Dr Anne Chiang, Ms Elizabeth Krueger, Ms Beth Sandy and Dr Erin Schenk. Published May 2025.
Topics:
• Introduction: Overview of Bispecific Antibodies (0:00)
• Biology of Small-Cell Lung Cancer (SCLC) and Review of Its Initial Management (13:37)
• Case: 63-year-old man — Ms Krueger (23:36)
• Current Role of Tarlatamab in Therapy for SCLC (33:40)
• Case: 70-year-old woman — Ms Sandy (43:41)
• Future Directions in the Management of SCLC (50:45)
• Case: 81-year-old man — Ms Krueger (1:01:24)
• Unique Considerations in SCLC Management (1:09:29)
• Case: 67-year-old woman — Ms Sandy (1:22:53)
The complete program, slides, CME information, and selected publications:
https://www.researchtopractice.com/ON...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
![[Webinar] Preclinical Strategies to Evaluate T Cell Engagers](https://imager.clipsaver.ru/VfJEXKLj6xQ/max.jpg)
